ETE Metrics

Tracking Progress to End the HIV Epidemic

The New York State Department of Health AIDS Institute uses 16 population-level metrics to help track progress towards Ending the Epidemic. Select metrics from the list below to view annual outcomes and ETE targets. Annual outcomes are viewable by sex, age group, and race/ethnicity for metrics where data are available.

Click on METRICS and FILTERS to expand menus and view page options.

metrics

Prevention And Testing (3)

PrEP Utilization

PrEP Utilization - Medicaid

HIV Status Aware

New Diagnoses And Linkage (4)

New HIV Diagnoses

Newly Diagnosed HIV - PWID

Concurrent AIDS Diagnoses

Linkage to Care

Retention And Care (7)

Receiving HIV Medical Care

Viral Suppression - Newly Diagnosed HIV

Viral Suppression - PLWDH

Viral Suppression - Receiving HIV Care

Sustained Viral Load Suppression

Time to AIDS Diagnosis

Stigma

DEATHS (1)

HIV Related Deaths

ETE: Bending the Curve (2)

ETE: Bending the Curve (NYS)

New Infections - Incidence

					    FILTERS 
					    
					
ETE: Bending the Curve Achieve fewer new HIV infections than deaths 2020 New HIV Infections 1,467 | 2020 Deaths among PLWDH 2,367

			                	Chart notes:
			                	Source: NYS HIV Surveillance System
Bending the curve metric displays HIV incidence minus all deaths among persons living with diagnosed HIV. 
 
			                
Explore data related to:
NEW INFECTIONS
New Infections - Incidence Reduce the number of estimated new HIV infections 2021 Actual 1,200 (NYC) 

			                	Chart notes:
			                	Source:  NYC DOHMH HIV Surveillance System
An estimated number of people who have acquired HIV; diagnosed and undiagnosed.
Incidence and undiagnosed estimates are calculated using a CDC methodology.
 
			                
Explore data related to:
NEW INFECTIONS
PrEP Utilization Increase the number of individuals filling prescriptions for PrEP to  65,0002022 Actual 50,558 | Goal 65,000

			                	Chart notes:
			                	 Source: IDV (Integrated Dataverse) from Symphony Health.
Number of individuals filling at least one prescription for Truvada or Descovy within the calendar year.
The FDA approved Descovy for PrEP on 10/3/2019.

			                
Explore data related to:
PrEP
PrEP Utilization - MedicaidIncrease the number of Medicaid recipients filling prescriptions for PrEP to 30,000 2022 Actual 12,428 | Goal 30,000

						    	Chart notes:
			                	Source: NYS Medicaid Data Warehouse.
Number of Medicaid recipients filling at least one prescription for Truvada or Descovy within the calendar year. 
The FDA approved Descovy for PrEP on 10/3/2019.

						    
Explore data related to:
PrEP
HIV Status AwareIncrease the percentage of persons living with HIV who know their serostatus to at least 98%2022 Actual 94% | Goal 98%

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
An estimated percentage of people living with HIV who have been diagnosed.
Incidence and undiagnosed estimates are calculated using CDC methodology released in 2022.

                            
Explore data related to:
TESTING
New HIV DiagnosesReduce the number of new HIV diagnoses by 55% to 1,5152022 Actual 2,318 | Goal 1,515

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
Number of persons newly diagnosed with HIV.

                            
Explore data related to:
NEW DIAGNOSES
Newly Diagnosed HIV – Persons with a History of Injection Drug UseReduce the percentage of persons newly diagnosed with HIV who indicate a history of injection drug use to 2.8%2022 Actual 3.1% | Goal 2.8%

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
Percent of persons newly diagnosed with HIV who indicate a history of injection drug use (IDU). Includes persons who indicate IDU and MSM/IDU history.

                            
Explore data related to:
NEW DIAGNOSES
Concurrent AIDS DiagnosesReduce the percentage of persons with a diagnosis of AIDS within 30 days of HIV diagnosis to 15.0%2022 Actual 18.0% | Goal 15.0% 

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
HIV infection with simultaneous AIDS diagnosis, or AIDS diagnosis (stage 3 HIV) within 30 days.

                            
Explore data related to:
CONCURRENT AIDS DIAGNOSES
Linkage to CareIncrease the percentage of newly diagnosed persons linked to HIV medical care within 30 days of diagnosis to at least 90%2022 Actual 81% | Goal 90% 

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
Newly diagnosed with any VL, CD4, or genotype within 30 days of diagnosis by diagnosis year.

                            
Explore data related to:
LINKAGE TO CARE
Receiving HIV Medical CareIncrease the percentage of persons living with diagnosed HIV (PLWDH) who receive HIV medical care to 90%2022 Actual 87% | Goal 90%

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
Any VL, CD4, or genotype test in a calendar year. 

                            
Explore data related to:
RECEIVING CARE
Viral Load Suppression – Newly Diagnosed HIV Increase the percentage of persons newly diagnosed with HIV who reach viral load suppression within 3 months of diagnosis to  75%2022 Actual 58% | Goal 75%

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
Viral load test suppressed (non-detectable or <200 copies/mL) within 91 days from the date of HIV diagnosis.

                            
Explore data related to:
VIRAL SUPPRESSION - NEW DIAGNOSES
Viral Load Suppression - PLWDHIncrease the percentage of PLWDH with suppressed viral load to  85% 2022 Actual 79% | Goal 85%

                             	Chart notes:
			                	Source: NYS HIV Surveillance System
Last viral load test in calendar year is non-detectable or <200 copies/mL.

                             
Explore data related to:
VIRAL SUPPRESSION - PLWDH
Viral Load Suppression - Receiving HIV Medical CareIncrease the percentage of PLWDH who receive HIV medical care with suppressed viral load to  95%2022 Actual 90% | Goal 95% 

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
Last viral load test in calendar year is non-detectable or <200 copies/mL, among those in care during the calendar year.

                            
Explore data related to:
VIRAL SUPPRESSION - RECEIVING CARE
Sustained Viral Load SuppressionIncrease the percentage of PLWDH with sustained viral load suppression to  75%2022 Actual 71% |  Goal 75% 

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
Viral load test suppressed (non-detectable or <200 copies/mL) on all viral load tests in the previous 2 years, among those with at least 2 viral load tests in the previous 2 years. 

                            
Explore data related to:
SUSTAINED VIRAL SUPPRESSION
Time to AIDS DiagnosisReduce the rate at which persons newly diagnosed with HIV progress to AIDS by  50%2020 Actual 4.1% | Goal 5.1% 

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
AIDS diagnosis within 2 years of HIV diagnosis. 

                            
Explore data related to:
AIDS DIAGNOSES
StigmaDecrease stigma experienced among PLWDH to at least  25% 2021 Actual 29% | Goal 25% 

                            	Chart notes:
			                	Source: NYS Medical Monitoring Project.
Based on the results of a 10 question scale looking at 4 dimensions of stigma (personalized stigma, disclosure concerns, negative self-image, and perceived public attitudes about people with HIV). 

                            
HIV Related DeathsReduce the percentage of deaths directly related to HIV to  20% 2021 Actual 18% | Goal 20% 

                            	Chart notes:
			                	Source: NYS HIV Surveillance System
The percentage of deaths that were related to HIV among persons with diagnosed HIV. Primary cause of death was used for HIV death ascertainment. 

                            
Explore data related to:
DEATHS AND HOSPITALIZATIONS
SELECT LOCATION
									
								
SELECT DEMOGRAPHICTotal 
Sex Female
Male
Age 0-19
20-24
25-29
30-39
40-49
50-59
60+
Race/Ethnicity iStarting with analyses of 2020 data, NYS implemented a new race/ethnicity classification methodology. This change reduces misclassification, with notable decreases in the percentage of individuals classified as Multi-Race or Hispanic, and increases in percentages of other categories. 

In 2021, an additional revision of the race/ethnicity classification methodology was introduced in accordance with an OMB directive separating the “Asian and Pacific Islander” category into two distinct categories, now called “Asian” and “Native Hawaiian / Pacific Islander.”
Asian
Black
Hispanic
Multi-Race
Native Am
Nat. Hawaiian/PI
White
SHOW TARGETS & GOAL

ETE Metrics Notes

Data sources for NYS Statewide and NYC are the NYS HIV Surveillance System and the NYC DOHMH Surveillance System, respectively, unless otherwise noted in chart notes above. Data as of March 2023.
The purple dotted line represents the extension of NYS ETE goals to 2024 due to the impact of COVID-19.
Data for the year 2020 should be interpreted with caution due to the impact of the COVID-19 pandemic on access to HIV testing, care-related services, and case surveillance activities.
NYS Statewide data is viewable by sex, age, or race/ethnicity, and NYC data is viewable by race/ethnicity for select metrics. No stratifications are available for Bending the Curve, Stigma, New Infections – Incidence, or HIV Status Aware. No race/ethnicity or age data are shown for either PrEP Utilization metric.
Starting with analyses of 2020 data, NYS implemented a new race/ethnicity classification methodology. This change reduces misclassification, with notable decreases in the percentage of individuals classified as Multi-Race or Hispanic, and increases in percentages of other categories. In 2021, an additional revision of the race/ethnicity classification methodology was introduced in accordance with an OMB directive separating the “Asian and Pacific Islander” category into two distinct categories, now called “Asian” and “Native Hawaiian / Pacific Islander.”
Proportions for some metrics filtered by age or race/ethnicity (e.g. Native American) are unstable due to low numbers; data are either hidden or should be interpreted with caution.
Incidence and undiagnosed estimates are calculated using CDC methodology released in 2022.
In 2019, NYS cautiously applauded the milestone of “Bending the Curve”, achieving the first ever decrease in HIV prevalence in NYS. Bending the curve is defined as the point where estimated HIV infections are lower than the number of deaths among people with diagnosed HIV and we achieve a decrease in the number of New Yorkers living with HIV. Our goal remains to keep new infections lower than deaths among people living with diagnosed HIV.